a(CHEBI:dopamine) decreases path(MESH:"Parkinson Disease")

PubMed:19126755

Parkinson’s disease (PD) is characterized by selective damage to dopaminergic nigrostriatal neurons and is clinically revealed by motor deficits, including rigidity, tremor, and bradykinesia. Dopamine replacement therapy (usually with L-dopa) is the most common treatment, although this drug loses efficacy over time.

Related Edges 6

• path(MESH:"Muscle Rigidity") positiveCorrelation path(MESH:"Parkinson Disease")
• path(MESH:"Parkinson Disease") positiveCorrelation path(MESH:Tremor)
• path(MESH:"Parkinson Disease") positiveCorrelation path(MESH:Hypokinesia)
• path(MESH:"Parkinson Disease") positiveCorrelation path(MESH:"Muscle Rigidity")
• path(MESH:Hypokinesia) positiveCorrelation path(MESH:"Parkinson Disease")
• path(MESH:Tremor) positiveCorrelation path(MESH:"Parkinson Disease")

MeSH

Dopaminergic Neurons

Text Location

Review

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.